c-Met is a new prognostic biomarker in glioblastoma patients

被引：0
|
作者：
Petterson, Stine A. [1 ,2 ]
Hermansen, Simon K. [1 ,2 ]
Dahlrot, Rikke H. [1 ,2 ,3 ]
Hansen, Steinbjorn [2 ,3 ]
Kristensen, Bjarne W. [1 ,2 ]
机构：
[1] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark
[2] Univ Southern Denmark, Inst Clin Res, Odense, Denmark
[3] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark
来源：
APMIS | 2014年 / 122卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [1] C-MET IS A NEW PROGNOSTIC BIOMARKER IN GLIOBLASTOMA PATIENTS
    Petterson, Stine Asferg
    Hermansen, Simon Kjaer
    Dahlrot, Rikke Hedegaard
    Hansen, Steinbjorn
    Kristensen, Bjarne Winther
    NEURO-ONCOLOGY, 2013, 15 : 156 - 156
  • [2] C-met, a new prognostic biomarker in glioblastoma multiforme.
    Dahlrot, Rikke Hedegaard
    Petterson, Stine Asferg
    Hermansen, Simon Kjaer
    Kristensen, Bjarne Winther
    Hansen, Steinbjorn
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] Signaling molecule c-Met is a biomarker for favorable prognostic in Hodgkin lymphoma
    Neagu, Monica
    Albulescu, Radu
    Tanase, Cristiana
    BIOMARKERS IN MEDICINE, 2012, 6 (02) : 197 - 197
  • [4] c-MET as a prognostic biomarker and therapeutic target in patients with poor prognostic pancreatic adenocarcinoma following surgical resection
    Neuzillet, Cindy
    Cros, Jerome
    Tijeras-Raballand, Annemilai
    Moroch, Julien
    De Mestier, Louis
    Bedossa, Pierre
    Paradis, Valerie
    Sauvanet, Alain
    Bachet, Jean-Baptiste
    De Gramont, Armand
    Cvitkovic, Esteban
    Raymond, Eric
    Hammel, Pascal
    Couvelard, Anne
    CANCER RESEARCH, 2014, 74 (19)
  • [5] PROGNOSTIC ROLE OF C-MET EXPRESSION IN BREAST CANCER PATIENTS
    Gisterek, I.
    Halon, A.
    Matkowski, R.
    Szelachowska, J.
    Lata, E.
    Biecek, P.
    Pudelka, M.
    Kornafei, J.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S244 - S244
  • [6] c-Met expression is associated with time to recurrence in patients with glioblastoma multiforme
    Liu, Wei
    Fu, Yibing
    Xu, Shangchen
    Ding, Feng
    Zhao, Guangyu
    Zhang, Kang
    Du, Chigang
    Pang, Bo
    Pang, Qi
    JOURNAL OF CLINICAL NEUROSCIENCE, 2011, 18 (01) : 119 - 121
  • [7] Prognostic role of c-met expression in breast cancer patients
    Gisterek, Iwona
    Lata, Ewelina
    Halon, Agnieszka
    Matkowski, Rafal
    Szelachowska, Jolanta
    Biecek, Przemyslaw
    Kornafel, Jan
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2011, 16 (05) : 173 - 177
  • [8] c-Met overexpression as an independent prognostic biomarker and therapeutic target in patients with poor prognostic pancreatic adenocarcinoma following surgical resection
    Neuzillet, Cindy
    Cros, Jerome
    Tijeras-Raballand, Annemilai
    De Gramont, Armand
    Moroch, Julien
    De Mestier, Louis
    Bedossa, Pierre
    Paradis, Valerie
    Sauvanet, Alain
    Bachet, Jean-Baptiste
    Cvitkovic, Esteban
    Raymond, Eric
    Hammel, Pascal
    Couvelard, Anne
    CANCER RESEARCH, 2015, 75
  • [9] METPRO: Evaluating prognostic value of c-Met protein overexpression and concurrent biomarker presence
    Le, X.
    Aggarwal, C.
    Simmons, A.
    Crawford, S. A.
    Ng, S.
    Chen, C.
    Karve, S.
    Stein, S.
    Woll, K.
    Ansell, P. J.
    Mistry, A.
    Bryant, D.
    Wistuba, I. I.
    ANNALS OF ONCOLOGY, 2024, 35 : S829 - S829
  • [10] Urinary c-Met levels as an indicator of disease progression in glioblastoma multiforme patients
    Shankavaram, U. T.
    Baschnagel, A.
    Russo, A.
    Jedlicka, K.
    Wernick, M.
    Smith, S.
    Cooley-Zglea, T.
    Citrin, D.
    Bottaro, D. P.
    Camphausen, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S215 - S215
12345